Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As TAVI Advances, Adjunctive Devices Multiply

Executive Summary

As researchers work to more fully understand the risks and durability of transcatheter aortic heart valve implantation (TAVI) procedures, device innovators are already attempting to engineer solutions to some of the more obvious areas of unmet need.

Advertisement

Related Content

TAVR Emerging As Next Big Application For Embolic Protection Devices
Transcatheter Valves At The Tipping Point
Device Trends To Watch In 2013
CardioLogical Solutions: Combining Forces To Deliver A Range Of TAVI Accessories
Drug-Coated Balloons Fuel Multibillion-Dollar Hopes
Ireland's Medtech Explosion
Market & Industry Briefs
TAVI Halo Shines On Embolic Protection Devices
TCT 2010: TAVI Takes Center Stage
Edwards: Transcatheter Valve Leader Proves You Can Go Home Again

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT035472

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel